Sanofi US has issued a voluntary recall of all Auvi-Q epinephrine auto-injectors currently on the market, including the the 0.15 mg and 0.3 mg strengths for hospitals, retailers and consumers, the company said in a release. The items are used to treat life-threatening allergic reactions. Sanofi has received 26 reports of suspected device malfunctions in the U.S. and Canada as of Oct. 26. The products can potentially deliver the wrong dosage. None of the malfunctions have been confirmed and there have been no fatal outcomes. Sanofi said customers should contact their healthcare providers for an alternate epinephrine auto-injectors.
Copyright © 2015 MarketWatch, Inc.
Continue Reading Below